The Report Store would like to introduce our newest Disease Analysis report enhancements based on your feedback and suggestions about our previous reports template. Disease Analysis (formerly Core Disease) reports additions include: Recent Events & Analyst Opinion; Consensus Forecasts; Probability of Success; and more.
Are you ready to experience the new reports interface? New enhancements include:
Highlighted high value content and analyst expertise
New, streamlined templates will highlight the expert analysis you’re accustomed to
Quick and easy access to high value analysis with significantly reduced duplication
More coverage than ever before
Disease Analysis reports additions include: Recent Events & Analyst Opinion; Consensus Forecasts; Probability of Success; and more. Company report additions include: Earnings Reviews; Key Management Quotes; Forecasts; and Opinions & Analysis
Additional hot topics coverage
Updated interface improves time spent covering hot topics and producing one-off pieces of content
Find relevant content faster than ever before
Find, get to and get through the information that matters to you
Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen and progesterone receptors, and does not involve the overexpression of human epidermal growth factor 2 (HER2). Datamonitor Healthcare estimates that in 2018 there were 2.1 million incident cases and 8.6 million five-year prevalent cases of breast cancer worldwide. By 2027, incident and prevalent cases of breast cancer are expected to increase to 2.3 million and 9.3 million cases, respectively.
Datamonitor Healthcare estimates that in 2018, there were 74.5 million prevalent cases of Alzheimer’s disease in adults aged 65 years and older worldwide, and forecasts that number to increase to 102.5 million prevalent cases by 2027.
Datamonitor Healthcare estimates that in 2018, there were 345.8 million prevalent cases of osteoporosis among adults aged 50 years and older worldwide, and forecasts that number to increase to 427.8 million prevalent cases by 2027.
Datamonitor Healthcare estimates that in 2018 there were approximately 1.5 billion prevalent cases of dyslipidemia in adults aged 20 years and older worldwide, and forecasts that number to increase to 1.7 billion prevalent cases by 2027.
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726